Synergistic effects of trastuzumab and gambogic acid on MDA-MB-453 breast cancer cell line
Trastuzumab is one of the most commonly used monoclonal antibodies in the treatment of breast cancer. It is effective because it binds to the HER2 receptor and inhibits the signaling pathways for proliferation and metastasis. However, intrinsic or acquired resistance resulting from the various signa...
Gardado en:
| Main Authors: | , |
|---|---|
| Formato: | Libro |
| Publicado: |
Polskie Towarzystwo Farmaceutyczne,
2023-07-01T00:00:00Z.
|
| Subjects: | |
| Acceso en liña: | Connect to this object online. |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|